30 articles, transcripts, and reports
Company Overview AngioDynamics is a medical technology company focused on restoring vascular blood flow, expanding cancer treatments, and improving patient...
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026. In Q2, net…
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Thursday reported a net loss for the first quarter of 2026. Revenues increased 12.2% on a year-over-year…
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) Wednesday reported a narrower net loss for the third quarter of 2025. Revenues decreased by 4%. Net loss,…
AngioDynamics Inc. (NASDAQ: ANGO) reported a net loss for the second quarter of 2025 as the medical device company’s revenues decreased 8%. Net loss, excluding…
Angiodynamics Inc (NASDAQ: ANGO) Q4 2023 earnings call dated Jul. 12, 2023 Corporate Participants: Jim Clemmer — Chief Executive Officer Steve Trowbridge — Chief Financial Officer Analysts: Jayson Bedford — Raymond…
Medical device company AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported an increase in adjusted profit for the fourth quarter of 2023, aided by a 5%…
AngioDynamics Inc. (NASDAQ: ANGO) Q3 2023 earnings call dated Mar. 30, 2023 Corporate Participants: Jim Clemmer — President and Chief Executive Officer Stephen A. TrowBridge — Executive Vice President…
The market reopening has created a conducive atmosphere to carry out elective medical procedures which were deferred on a large scale during the pandemic to…
